Dr. Peter Chang
Overview
Peter Chang is a Urologist in Boston, Massachusetts. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Prostate Cancer, Bladder Cancer, Urothelial Cancer, Prostatectomy, and Nephrectomy.
His clinical research consists of co-authoring 95 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 12 articles in the study of Bladder Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- PPO
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
330 Brookline Avenue, Shapiro 3, Boston, MA 02215
100 Highland Street, Suite 202, Milton, MA 02186
148 Chestnut Street, 1st Floor, Needham, MA 02492
Additional Areas of Focus
Dr. Chang has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Brigham And Women's Faulkner Hospital, Department Of Urology
Dr. Mossanen is a graduate of the University of California, Los Angeles (UCLA) in Los Angeles, CA and received his medical degree from the David Geffen School of Medicine at UCLA. He also holds a Master of Public Health from the Harvard T.H. Chan School of Public Health in Boston, MA. Dr. Mossanen completed a residency in Urology from the University of Washington in Seattle, WA followed by a fellowship in Urologic Oncology in the Combined Harvard Urologic Oncology Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Mossanen has been board certified by the American Board of Urology since 2020.His research and clinical interests include: bladder cancer, kidney cancer, kidney masses/cysts, laparoscopic surgery, penile cancer, prostate cancer, robotic surgery, testicular cancer. Dr. Mossanen is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Penile Cancer, Cystectomy, and Nephrectomy.
Brigham And Women's Faulkner Hospital, Department Of Urology
Dr. Mark A. Preston is a urologic surgeon at Brigham and Women’s Hospital and Associate Professor of Surgery at Harvard Medical School. Dr. Preston received his Medical Degree from the University of Ottawa in Canada, where he also completed his residency training in Urology. He completed a three-year accredited fellowship in Urologic Oncology at Massachusetts General Hospital including a Masters of Public Health from the Harvard School of Public Health with a concentration in clinical effectiveness. He is board certified in Urology.Dr. Preston’s clinical interests include urologic oncology (bladder, kidney, prostate and testicular cancer) and minimally invasive surgery. Dr. Preston’s research focuses on the epidemiology of prostate and kidney cancer risk with an emphasis on predictive biomarkers and pharmacoepidemiology. Dr. Preston is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Prostatectomy.
Dana-Farber Cancer Institute, Inc.
Adam Kibel is a Urologist in Boston, Massachusetts. Dr. Kibel is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Cystectomy. Dr. Kibel is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Prostate CancerDr. Chang isElite. Learn about Prostate Cancer.
- Distinguished
- Bladder CancerDr. Chang isDistinguished. Learn about Bladder Cancer.
- Familial Prostate CancerDr. Chang isDistinguished. Learn about Familial Prostate Cancer.
- NephrectomyDr. Chang isDistinguished. Learn about Nephrectomy.
- Non-Muscle Invasive Bladder CancerDr. Chang isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- ProstatectomyDr. Chang isDistinguished. Learn about Prostatectomy.
- Urothelial CancerDr. Chang isDistinguished. Learn about Urothelial Cancer.
- Advanced
- Chromophobe Renal Cell Carcinoma
- Clear Cell SarcomaDr. Chang isAdvanced. Learn about Clear Cell Sarcoma.
- Congenital Mesoblastic NephromaDr. Chang isAdvanced. Learn about Congenital Mesoblastic Nephroma.
- CystectomyDr. Chang isAdvanced. Learn about Cystectomy.
- Familial Wilms Tumor 2Dr. Chang isAdvanced. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Chang isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Experienced
- Bietti Crystalline Dystrophy (BCD)Dr. Chang isExperienced. Learn about Bietti Crystalline Dystrophy (BCD).
- Bilateral HydronephrosisDr. Chang isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder StonesDr. Chang isExperienced. Learn about Bladder Stones.
- EmpyemaDr. Chang isExperienced. Learn about Empyema.
- EndoscopyDr. Chang isExperienced. Learn about Endoscopy.
- Enlarged Prostate (BPH)Dr. Chang isExperienced. Learn about Enlarged Prostate (BPH).